AI model accurately predicts breast cancer risk across multiple races

A deep learning artificial intelligence (AI) model that was developed using only mammogram image biomarkers accurately predicted both ductal carcinoma in situ (DCIS) and invasive carcinoma, according to research being presented today at the annual meeting of the Radiological Society of North America.

BMS bags UK advanced melanoma win for Opdualag – Pharmaceutical Technology

Share this article The MHRA approved Bristol Myers Squibb’s Opdualag for advanced melanoma. Credit: Bloomberg via Getty Images The UK Medicines and Healthcare products Regulatory

December 28, 2023

How did hiring in the French pharma industry perform in Q3 2023? – Pharmaceutical Technology

Notably, Management Occupations jobs accounted for an 8% share of the French pharma industry new job postings in Q3 2023, down by 40% over the

October 19, 2023

With new acquisitions, Humana and CVS hope to turn members into patients

Both Humana and CVS Health on Wednesday touted plans to aggressively scale their primary care clinics for seniors and funnel Medicare members into those clinics.

August 2, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.